Topic Hub
Monitoring
Use this hub when readers need to connect care surveillance questions to the broader FKRP evidence and guidance structure.
Guides
Start with the site-level reference pages that define this topic.
Guide
Monitoring and Care
FKRP-related disease is usually managed through a multidisciplinary model. Monitoring is not only about neurology. Cardiology, pulmonology, sleep evaluation, rehabilitation, genetics, and practical family coordination all matter to safe long-term care.
Guide
For Clinicians
This page is a clinician-facing orientation route through the FKRP site. It is designed to support rapid review by focusing on the disease spectrum, monitoring domains, and source-linked follow-up pages rather than broad generic neuromuscular background.
Guide
For Families
This page is the family-friendly entry point into the FKRP site. It is designed to help non-specialists understand the main ideas quickly, know which questions are worth bringing to clinic, and move from confusion toward a structured understanding of the condition.
Guide
Physiotherapy
Physiotherapy in FKRP-related disease should turn the exercise evidence into age-aware, condition-aware plans that protect function, recovery, breathing, and participation.
Papers
Use the paper summaries for dated evidence and limitations.
Paper Summary
Discordant Cardiomyopathy Phenotypes in Siblings With Homozygous FKRP c.1100T>C
Two-sibling case report describing different cardiac courses despite the same homozygous FKRP variant.
Paper Summary
Quantitative Measurement of Glycosylated Alpha-Dystroglycan as a Biomarker for Disease Severity in LGMD2I/R9
Prospective 12-month observational study of muscle-biopsy glycosylated alpha-dystroglycan measurements in genetically confirmed LGMD2I/R9.
Paper Summary
Oral ribose supplementation in dystroglycanopathy: A single case study
A six-month oral D-ribose study reported in one adult with FKRP-related LGMD2I.
Paper Summary
Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance
A small FKRP cohort comparing cardiovascular magnetic resonance with electrocardiography and echocardiography.
Studies
Use the study records for current trial, registry, and cohort context.
Study Record
A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
Phase 3 corticosteroid study record evaluating deflazacort in adults with FKRP-related LGMD2I, ultimately terminated early.
Study Record
BBP-418 (Ribitol) FORTIFY Trial in LGMD2I/LGMDR9
Phase 3 randomized ribitol trial in FKRP-related LGMD2I/LGMDR9, with trial details and separately dated sponsor-reported regulatory updates.
Pages
Use these site-level pages when you need practical support or field-wide status context.
Therapies
Use these support summaries to connect intervention domains back to the wider library.
Therapy Summary
Cardiac surveillance and treatment planning
Cardiac management in FKRP starts with surveillance discipline, because meaningful involvement can be present even when limb symptoms dominate the conversation.
Therapy Summary
Mobility and equipment support
Equipment support is part of care quality in FKRP, not a sign that rehabilitation goals have ended.
Therapy Summary
Physiotherapy and pacing
Physiotherapy in FKRP is most useful when it supports function, pacing, and participation rather than chasing isolated strength gains.
Therapy Summary
Respiratory support
Respiratory support becomes relevant when overnight breathing, cough effectiveness, or ventilatory reserve start to change, even if daytime weakness seems modest.
Glossary